We are live on ! Find out more
GLSI icon

Greenwich LifeSciences

51 hedge funds and large institutions have $11.2M invested in Greenwich LifeSciences in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

11% more funds holding

Funds holding: 4651 (+5)

1% more capital invested

Capital invested by funds: $11.1M → $11.2M (+$87K)

0.38% more ownership

Funds ownership: 8.84%9.21% (+0.38%)

Holders
51
Holders Change
+5
Holders Change %
+10.87%
% of All Funds
0.67%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
20
Reduced
11
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$3.33M +$143K +14,990 +4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.44M -$12.4K -1,304 -0.5%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.26M +$18.8K +1,972 +1%
Northern Trust
4
Northern Trust
Illinois
$751K -$17.6K -1,854 -2%
State Street
5
State Street
Massachusetts
$746K +$67K +7,039 +9%
Marshall Wace
6
Marshall Wace
United Kingdom
$509K +$534K +56,142 New
Millennium Management
7
Millennium Management
New York
$310K +$325K +34,181 New
Renaissance Technologies
8
Renaissance Technologies
New York
$248K +$141K +14,800 +118%
SO
9
STRS Ohio
Ohio
$181K +$13.3K +1,400 +8%
Charles Schwab
10
Charles Schwab
California
$173K +$399 +42 +0.2%
HighTower Advisors
11
HighTower Advisors
Illinois
$154K +$14.8K +1,560 +10%
Goldman Sachs
12
Goldman Sachs
New York
$150K +$157K +16,498 New
Bank of New York Mellon
13
Bank of New York Mellon
New York
$132K +$32.3K +3,393 +30%
Citadel Advisors
14
Citadel Advisors
Florida
$125K +$4.32K +454 +3%
Morgan Stanley
15
Morgan Stanley
New York
$107K +$21.1K +2,219 +23%
Barclays
16
Barclays
United Kingdom
$96K +$37.6K +3,949 +60%
RhumbLine Advisers
17
RhumbLine Advisers
Massachusetts
$81.4K -$6.64K -698 -7%
New York State Common Retirement Fund
18
New York State Common Retirement Fund
New York
$54.4K
Bank of America
19
Bank of America
North Carolina
$47.5K -$1.16K -122 -2%
Mirae Asset Global ETFs Holdings
20
Mirae Asset Global ETFs Holdings
Hong Kong
$31.6K -$1.48K -156 -4%
TRCT
21
Tower Research Capital (TRC)
New York
$29.6K +$21.5K +2,256 +224%
Wells Fargo
22
Wells Fargo
California
$28.6K +$2.27K +239 +8%
Fidelity Investments
23
Fidelity Investments
Massachusetts
$27.6K +$24.5K +2,579 +557%
JP Morgan Chase
24
JP Morgan Chase
New York
$26.1K -$1.67K -175 -6%
PFSRSONJ
25
Police & Firemen's Retirement System of New Jersey
New Jersey
$25.1K +$26.3K +2,768 New

GLSI Hedge Fund Activity: Q2 2025 in Review

51 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q2 2025, worth a combined $11.2M — up 0.78% from $11.1M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new GLSI positions and 3 closed out — a net gain of 6 holders — while 20 added to existing stakes and 11 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $534K. The largest seller was Corebridge Financial, exiting entirely with an estimated $28.5K sold.

  • 51 institutional investors held Greenwich LifeSciences (GLSI) as of Q2 2025, up from 46 in Q1 2025.
  • Funds reported $11.2M of Greenwich LifeSciences stock for Q2 2025, up 0.78% quarter-over-quarter.
  • 9 funds opened new Greenwich LifeSciences positions in Q2 2025 and 3 closed out, a net change of +6 holders.
  • The largest Greenwich LifeSciences buyer in Q2 2025 was Marshall Wace, an estimated $534K added.
  • The largest Greenwich LifeSciences seller in Q2 2025 was Corebridge Financial, an estimated $28.5K sold.

Based on aggregated 13F filings for Q2 2025.